Altimmune
ALT
ALT
30 hedge funds and large institutions have $4.37M invested in Altimmune in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Holders
30
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$813K | |
| 2 | +$137K | |
| 3 | +$60K | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$56K |
| 5 |
JPMorgan Chase & Co
New York
|
+$53.2K |
Top Sellers
| 1 | -$165K | |
| 2 | -$49K | |
| 3 | -$36.7K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$31.8K |
| 5 |
SBSB
Sullivan, Bruyette, Speros & Blaney
Mclean,
Virginia
|
-$29K |